These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9788259)

  • 21. Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies.
    Buergy D; Weber T; Maurer GD; Mudduluru G; Medved F; Leupold JH; Brauckhoff M; Post S; Dralle H; Allgayer H
    Int J Cancer; 2009 Aug; 125(4):894-901. PubMed ID: 19480010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trefoil factor 3 immunohistochemical characterization of follicular thyroid lesions from tissue microarray.
    Patel MR; Bryson PC; Shores CG; Hart CF; Thorne LB; Deal AM; Zanation AM
    Arch Otolaryngol Head Neck Surg; 2009 Jun; 135(6):590-6. PubMed ID: 19528408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement of the expression of oncofetal fibronectin mRNA in thyroid carcinomas by competitive reverse transcription-polymerase chain reaction.
    Higashiyama T; Takano T; Matsuzuka F; Liu G; Miyauchi A; Yokozawa T; Morita S; Kuma K; Shiba E; Noguchi S; Amino N
    Thyroid; 1999 Mar; 9(3):235-40. PubMed ID: 10211598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen-receptor protein in thyroid neoplasms. An immunohistochemical analysis of papillary carcinoma, follicular carcinoma, and follicular adenoma.
    Diaz NM; Mazoujian G; Wick MR
    Arch Pathol Lab Med; 1991 Dec; 115(12):1203-7. PubMed ID: 1768209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of heterogeneous ribonucleoprotein A(2)/B(1) expression in thyroid neoplasms.
    Bidot P; Morgan M; Zhukov T; Tannenbaum M; Tockman MS
    Endocr Pract; 2001; 7(3):157-61. PubMed ID: 11421561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PRDX1 and PRDX6 are repressed in papillary thyroid carcinomas via BRAF V600E-dependent and -independent mechanisms.
    Nicolussi A; D'Inzeo S; Mincione G; Buffone A; Di Marcantonio MC; Cotellese R; Cichella A; Capalbo C; Di Gioia C; Nardi F; Giannini G; Coppa A
    Int J Oncol; 2014 Feb; 44(2):548-56. PubMed ID: 24316730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in integrin and E-cadherin expression in neoplastic versus normal thyroid tissue.
    Serini G; Trusolino L; Saggiorato E; Cremona O; De Rossi M; Angeli A; Orlandi F; Marchisio PC
    J Natl Cancer Inst; 1996 Apr; 88(7):442-9. PubMed ID: 8618236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. S-100 protein+ dendritic cells and CD34+ dendritic interstitial cells in thyroid lesions.
    Batistatou A; Zolota V; Scopa CD
    Endocr Pathol; 2002; 13(2):111-5. PubMed ID: 12165658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of hepatocyte growth factor in Hashimoto's thyroiditis with nodular lesions.
    Ruggeri RM; Sciacchitano S; Trimarchi F; Barresi G; Trovato M
    Eur J Histochem; 2007; 51(3):193-8. PubMed ID: 17921114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peroxisome proliferator activated receptor gamma immunohistochemical expression in human papillary thyroid carcinoma tissues. Possible relationship to lymph node metastasis.
    Galusca B; Dumollard JM; Chambonniere ML; Germain N; Prades JM; Péoc'h M; Estour B
    Anticancer Res; 2004; 24(3b):1993-7. PubMed ID: 15274390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RET/PTC fusion gene rearrangements in Japanese thyroid carcinomas.
    Nibu K; Otsuki N; Nakao K; Sugasawa M; Rothstein JL
    Eur Arch Otorhinolaryngol; 2005 May; 262(5):368-73. PubMed ID: 15368067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Papillary carcinoma of the thyroid: hepatocyte growth factor (HGF) stimulates tumor cells to release chemokines active in recruiting dendritic cells.
    Scarpino S; Stoppacciaro A; Ballerini F; Marchesi M; Prat M; Stella MC; Sozzani S; Allavena P; Mantovani A; Ruco LP
    Am J Pathol; 2000 Mar; 156(3):831-7. PubMed ID: 10702399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and significance of c-met protein in papillary thyroid carcinoma.
    Inaba M; Sato H; Abe Y; Umemura S; Ito K; Sakai H
    Tokai J Exp Clin Med; 2002 Aug; 27(2):43-9. PubMed ID: 12472169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression of cytokeratin19, galectin-3 and HBME-1 in thyroid lesions and their differential diagnoses].
    Teng XD; Wang LJ; Yao HT; Li J; Ding W; Yan LP
    Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):212-6. PubMed ID: 15256110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocyte growth factor (HGF) downregulates thrombospondin 1 (TSP-1) expression in thyroid papillary carcinoma cells.
    Scarpino S; Di Napoli A; Taraboletti G; Cancrini A; Ruco LP
    J Pathol; 2005 Jan; 205(1):50-6. PubMed ID: 15526350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of CD44 and cyclin D1 in fine needle aspiration cytology of papillary thyroid carcinoma.
    Kim JY; Cho H; Rhee BD; Kim HY
    Acta Cytol; 2002; 46(4):679-83. PubMed ID: 12146030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased expression of Met protein is associated with up-regulation of hypoxia inducible factor-1 (HIF-1) in tumour cells in papillary carcinoma of the thyroid.
    Scarpino S; Cancellario d'Alena F; Di Napoli A; Pasquini A; Marzullo A; Ruco LP
    J Pathol; 2004 Mar; 202(3):352-8. PubMed ID: 14991901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatocyte growth factor (HGF) stimulates tumour invasiveness in papillary carcinoma of the thyroid.
    Scarpino S; Stoppacciaro A; Colarossi C; Cancellario F; Marzullo A; Marchesi M; Biffoni M; Comoglio PM; Prat M; Ruco LP
    J Pathol; 1999 Dec; 189(4):570-5. PubMed ID: 10629560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunocytochemical evaluation of HBME-1, CA 19-9, and CD-15 (Leu-M1) in fine-needle aspirates of thyroid nodules.
    van Hoeven KH; Kovatich AJ; Miettinen M
    Diagn Cytopathol; 1998 Feb; 18(2):93-7. PubMed ID: 9484636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of c-erbB-2 protein in papillary thyroid carcinomas.
    Haugen DR; Akslen LA; Varhaug JE; Lillehaug JR
    Br J Cancer; 1992 Jun; 65(6):832-7. PubMed ID: 1352125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.